NervGen Pharma Corp. (NGEN)

NervGen Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	350	153	122	69	98	61
Market Cap Growth	142.68%	25.91%	75.67%	-29.11%	59.23%	38.56%
Enterprise Value	342	139	111	49	91	55
Last Close Price	4.45	2.18	2.04	1.19	2.13	1.74
PB Ratio	-	85.68	-80.10	6.98	7.36	13.23
P/TBV Ratio	-	104.55	-	7.21	7.58	14.37
Debt / Equity Ratio	-0.01	0.04	-0.10	0.02	-	-
Net Debt / Equity Ratio	3.85	-6.66	5.71	-1.65	-1.01	-0.95
Net Debt / EBITDA Ratio	0.45	0.69	0.65	0.97	1.33	0.50
Net Debt / FCF Ratio	0.68	1.02	1.01	1.25	2.05	0.89
Quick Ratio	0.73	1.05	0.79	2.20	15.76	7.50
Current Ratio	0.79	1.13	0.83	2.27	16.16	8.21
Return on Equity (ROE)	-820.11%	-8460.20%	-390.89%	-136.87%	-111.94%	-190.21%
Return on Assets (ROA)	-88.77%	-95.24%	-59.88%	-68.90%	-65.17%	-104.12%
Return on Capital Employed (ROCE)	857.90%	-964.50%	933.90%	-168.60%	-76.20%	-189.10%
Earnings Yield	-5.24%	-10.87%	-13.91%	-22.07%	-10.28%	-14.28%
FCF Yield	-3.50%	-7.63%	-7.02%	-18.96%	-6.68%	-8.05%
Buyback Yield / Dilution	-10.41%	-13.55%	-12.61%	-34.00%	-22.35%	-23.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.